Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer

Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer

The treatment of non-small cell lung cancer (NSCLC) has recently evolved with the introduction of targeted therapy based on the use of tyrosine kinase inhibitors (TKIs) in patients with certain gene alterations, including <i>EGFR</i>, <i>ALK</i>, <i>ROS1</i>, <...

Full description

Bibliographic Details
Main Authors: Karolina Buszka, Aliki Ntzifa, Barbara Owecka, Paula Kamińska, Agata Kolecka-Bednarczyk, Maciej Zabel, Michał Nowicki, Evi Lianidou, Joanna Budna-Tukan
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cells
Subjects:
circulating tumor cells (CTCs)
cell-free DNA (cfDNA)
exosomes
tumor-educated platelets (TEPs)
liquid biopsy
non-small cell lung cancer (NSCLC)
Online Access:https://www.mdpi.com/2073-4409/11/18/2871

Internet

https://www.mdpi.com/2073-4409/11/18/2871

Similar Items